ReProMSig: an integrative platform for development and application of reproducible multivariable models for cancer prognosis supporting guideline-based transparent reporting.

Zhao, Tingting; Cao, Lihua; Ji, Jiafu; Chang, David K; Wu, Jianmin

Zhao, Tingting; Cao, Lihua; Ji, Jiafu; Chang, David K; Wu, Jianmin.

Afiliación

Zhao T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Cao L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Ji J; Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Chang DK; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Scotland, United Kingdom.
Wu J; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom.

Brief Bioinform ; 24(5)2023 09 20.

Article en En | MEDLINE | ID: mdl-37529934

Asunto(s)

Lista de Verificación; Neoplasias; Humanos; Medicina de Precisión; Neoplasias/diagnóstico; Neoplasias/genética; Neoplasias/terapia

Palabras clave

biomarker development; molecular signature; multivariable prognosis model; transparent reporting; web portal

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lista de Verificación / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Brief Bioinform Asunto de la revista: BIOLOGIA / INFORMATICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google